CA Stock MarketDetailed Quotes

NGEN NervGen Pharma Corp

Watchlist

2.900
+0.020+0.69%

15min DelayMarket Closed Feb 24 16:00 ET

203.89MMarket Cap-7.63P/E (TTM)

NervGen Pharma Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NervGen Pharma Corp Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2022/Q4	0.000 / 0.000	--
--	2022/Q3	0.000 / 0.000	--
--	2022/Q2	0.000 / 0.000	--
--	2021/Q4	0.000 / 0.000	--
--	2021/Q3	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2022/Q40.000 / 0.000--

--2022/Q30.000 / 0.000--

--2022/Q20.000 / 0.000--

--2021/Q40.000 / 0.000--

--2021/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

NervGen Pharma Corp Earnings Reports

NervGen Pharma Corp: INTERIM MDA EN

Nov 14, 2024 08:01 ET

NervGen Pharma Corp: INTERIM FINANCIAL STATEMENTSREPORT EN

Nov 14, 2024 08:00 ET